Daniel Tarquinio
Expertise in
5
conditions

Dr. Daniel Tarquinio

Neurology
4445 South Lee Street, Suite 310, 
Buford, GA 
Accepting New Patients
Offers Telehealth
22 Years of Experience
Expertise in
5
conditions
4445 South Lee Street, Suite 310, 
Buford, GA 

Overview

Daniel Tarquinio is a Neurologist in Buford, Georgia. Dr. Tarquinio has been practicing medicine for over 22 years is highly rated in 5 conditions, according to our data. His top areas of expertise are Rett Syndrome, Epilepsy, Seizures, and Absence Seizure. Dr. Tarquinio is currently accepting new patients.

His clinical research consists of co-authoring 33 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution

University Of New England College Of Osteopathic Medicine, 2004

Residency

Boston Medical Center, Child Neurology

Specialties

Neurology

Licenses

Pediatrics in FL

Board Certifications

American Board Of Psychiatry & Neurology, Neurology With Special Qualification In Child Neurology - 2013

Fellowships

Harvard Medical School, Behavioral Neurology & Neuropsychiatry, 2014
Miami Children's Hospital, Clinical Neurophysiology, 2012

Hospital Affiliations

Northeast Georgia Medical Center, Inc

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Ambetter
  • EPO
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 18 Less Insurance Carriers -

Locations

Northeast Georgia Physicians Group Neurology
4445 South Lee Street, Suite 310, Buford, GA 30518
Other Locations
Northeast Georgia Physicians Group Neurology
1315 Jesse Jewell Parkway Northeast, Suite 300, Gainesville, GA 30501

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Global Study of a Single, One-Time Dose of AVXS-101 Delivered to Infants With Genetically Diagnosed and Pre-symptomatic Spinal Muscular Atrophy With Multiple Copies of SMN2
A Global Study of a Single, One-Time Dose of AVXS-101 Delivered to Infants With Genetically Diagnosed and Pre-symptomatic Spinal Muscular Atrophy With Multiple Copies of SMN2
Enrollment Status: Completed
Publish Date: January 26, 2026
Intervention Type: Biological
Study Drug: Onasemnogene Abeparvovec-Xioi
Study Phase: Phase 3
An Open-Label, Single-Dose, Pharmacokinetics Study of VALTOCO® With Open-Label Safety Period in Pediatric Subjects With Epilepsy
An Open-Label, Single-Dose, Pharmacokinetics Study of VALTOCO® With Open-Label Safety Period in Pediatric Subjects With Epilepsy
Enrollment Status: Completed
Publish Date: August 11, 2025
Intervention Type: Drug
Study Drug: Diazepam Nasal Spray [Valtoco]
Study Phase: Phase 1/Phase 2
A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Assess the Safety, Tolerability and Efficacy of Oral Ketamine for Patients With Rett Syndrome
A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Assess the Safety, Tolerability and Efficacy of Oral Ketamine for Patients With Rett Syndrome
Enrollment Status: Completed
Publish Date: May 28, 2024
Intervention Type: Drug
Study Drug: Ketamine
Study Phase: Phase 2
A Multicenter, Open-Label Proof-of-Concept Trial of Ganaxolone in Children With PCDH19 Female Pediatric Epilepsy and Other Rare Genetic Epilepsies Followed by 52 Week Open-Label Treatment
A Multicenter, Open-Label Proof-of-Concept Trial of Ganaxolone in Children With PCDH19 Female Pediatric Epilepsy and Other Rare Genetic Epilepsies Followed by 52 Week Open-Label Treatment
Enrollment Status: Completed
Publish Date: March 21, 2023
Intervention Type: Drug
Study Drug: Ganaxolone
Study Phase: Phase 2
A Phase 2a, Safety, Tolerability, Pharmacokinetics, and Quantitative EEG Study of CX-8998 in Adolescents and Adults With Idiopathic Generalized Epilepsy With Absence Seizures
A Phase 2a, Safety, Tolerability, Pharmacokinetics, and Quantitative EEG Study of CX-8998 in Adolescents and Adults With Idiopathic Generalized Epilepsy With Absence Seizures
Enrollment Status: Completed
Publish Date: September 08, 2022
Intervention Type: Drug
Study Phase: Phase 2
A Double-Blind, Placebo-Controlled, Inpatient, Dose-Ranging Efficacy Study of Staccato Alprazolam (STAP-001) in Subjects With Epilepsy With a Predictable Seizure Pattern
A Double-Blind, Placebo-Controlled, Inpatient, Dose-Ranging Efficacy Study of Staccato Alprazolam (STAP-001) in Subjects With Epilepsy With a Predictable Seizure Pattern
Enrollment Status: Completed
Publish Date: February 03, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Phase 3, Randomized, Double-blind, Placebo-controlled, Crossover Study to Assess the Efficacy and Safety of UX007 in the Treatment of Movement Disorders Associated With Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
A Phase 3, Randomized, Double-blind, Placebo-controlled, Crossover Study to Assess the Efficacy and Safety of UX007 in the Treatment of Movement Disorders Associated With Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
Enrollment Status: Terminated
Publish Date: June 16, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 6 Less Clinical Trials

33 Total Publications

Triheptanoin Did Not Show Benefit versus Placebo for the Treatment of Paroxysmal Movement Disorders in Glut1 Deficiency Syndrome: Results of a Randomized Phase 3 Study.
Triheptanoin Did Not Show Benefit versus Placebo for the Treatment of Paroxysmal Movement Disorders in Glut1 Deficiency Syndrome: Results of a Randomized Phase 3 Study.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: February 14, 2024
Similar Doctors
Expertise in
19
conditions
Dr. Nancy Newman
Neurology
Expertise in
19
conditions
Dr. Nancy Newman
Neurology

Emory Medical Group LLC

1365 Clifton Rd NE # B, 
Atlanta, GA 
 (45.7 miles away)
404-778-5360
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Nancy Newman is a Neurologist in Atlanta, Georgia. Dr. Newman is highly rated in 19 conditions, according to our data. Her top areas of expertise are Leber Hereditary Optic Neuropathy (LHON), Optic Nerve Atrophy, Pseudotumor Cerebri Syndrome, Increased Intracranial Pressure, and Embolectomy.

Stewart A. Factor
Expertise in
20
conditions
Dr. Stewart A. Factor
Neurology
Expertise in
20
conditions
Dr. Stewart A. Factor
Neurology

Emory Brain Health Center

12 Executive Park Drive Northeast, 
Atlanta, GA 
 (43.8 miles away)
404-778-3444
Experience:
44+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Stewart Factor is a Neurologist in Atlanta, Georgia. Dr. Factor has been practicing medicine for over 44 years is highly rated in 20 conditions, according to our data. His top areas of expertise are Parkinson's Disease, Movement Disorders, Tardive Dyskinesia, Deep Brain Stimulation, and Thalamotomy.

Hyder A. Jinnah
Expertise in
15
conditions
Dr. Hyder A. Jinnah
Neurology
Expertise in
15
conditions
Dr. Hyder A. Jinnah
Neurology

Emory Brain Health Center

12 Executive Park Drive Northeast, 
Atlanta, GA 
 (43.8 miles away)
404-778-3444
Experience:
33+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Hyder Jinnah is a Neurologist in Atlanta, Georgia. Dr. Jinnah has been practicing medicine for over 33 years is highly rated in 15 conditions, according to our data. His top areas of expertise are Benign Essential Blepharospasm, Drug Induced Dyskinesia, Focal Dystonia, Torticollis, and Deep Brain Stimulation.

Frequently Asked Questions about Dr. Daniel Tarquinio

How do I make an appointment with Dr. Daniel Tarquinio?

You can book an appointment with Dr. Daniel Tarquinio by calling their office at 770-219-6520. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Daniel Tarquinio a top-rated expert for Rett Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Daniel Tarquinio is classified as an Elite expert for Rett Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Daniel Tarquinio specialize in?

While Dr. Daniel Tarquinio is a Neurology, they have specific expertise in Rett Syndrome, Epilepsy, and Seizures. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.

Does Dr. Daniel Tarquinio participate in research or clinical trials?

Yes. Dr. Daniel Tarquinio has published 33 articles and abstracts on conditions like Rett Syndrome. You can view a list of Dr. Daniel Tarquinio's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Daniel Tarquinio accept my insurance?

Dr. Daniel Tarquinio accepts most major insurance plans, including Aetna and Alliant Health. We recommend calling the office directly at 770-219-6520 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Tarquinio's expertise for a condition
ConditionClose
View All 8 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile